<unk>  is an enzyme replacement therapy that is FDA approved for the treatment of Lysosomal alpha-1,4-glucosidase deficiency - infantile onset and lysosomal alpha-1,4-glucosidase deficiency - juvenile onset.. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include hypertension, chest discomfort, tachycardia, flushing, hyperhidrosis, rash, urticaria, constipation, diarrhea, vomiting, anemia, IgG antibody development, muscle twitch, tremor, cough, tachypnea, infusion reactions, and fever..
Alglucosidase alfa
Tetracosactide
Vestronidase alfa
Sincalide
Hydroxyethyl starch
Icodextrin
Insulin degludec
Cerliponase alfa